• No results found

Guide for Writing a Short Proposal

N/A
N/A
Protected

Academic year: 2021

Share "Guide for Writing a Short Proposal"

Copied!
10
0
0

Loading.... (view fulltext now)

Full text

(1)

Guide for Writing a Short

Proposal

Life Sciences PRECISION MEDICINE Call 2016

November 2015

Vienna Science and Technology Fund (WWTF) Schlickgasse 3/12

1090 Vienna, Austria

T: +43 (0) 1 4023143-12 (Cornelia Schrauf) F: +43 (0) 1 4023143-20

(2)

2

About WWTF

The Vienna Science and Technology Fund (WWTF) is the only larger Austrian private non-profit organization established to promote science and research. WWTF started its funding activities in 2003. According to its statutes, WWTF aims to fund excellent scientific re-search(ers) following the highest international standards in order to promote Vienna as a city of science and research.

WWTF provides substantial funding for larger multi-annual research projects at home institu-tions located in Vienna (“Project Funding”), as well as striving to attract excellent researchers from abroad to Vienna (“Science Chairs”, “Vienna Research Groups for Young Investiga-tors”). WWTF runs calls resulting in a tough competition for funding with an average success rate of less than 20% (a rate that varies, however, from call to call).

Currently, WWTF runs the following thematic programmes: “Life Sciences” (*2003), “Mathe-matics and ...” (*2004), “Information and Communication Technology” (*2008), and “Cogni-tive Sciences” (*2011). The financial resources of WWTF originate from the “Privatstiftung

zur Verwaltung von Anteilsrechten” from which WWTF receives about seven to nine million €

annually.

In addition, WWTF runs the following funding programmes for the City of Vienna: The “Uni-versity Infrastructure Programme” (*2006), “Social Sciences and Humanities in Vienna” (*2008), “Vienna Research Groups for Young Investigators” (*2010) with a total annual fund-ing volume of about 5 million €.

While the thematic funding programmes are established in close coordination with Viennese RTD policy and initiatives, the review and selection process lies strictly in the hands of inter-national scientists not employed in Austria. The main selection criterion for funding is excel-lent scientific quality according to the highest international standards. For each call, an ap-propriate international expert jury is established. Additionally, for each proposal a number of written peer reviews are obtained. In a two-day meeting in Vienna the juries formulate a fund-ing recommendation based on the reviews and on their own expertise. This recommendation is then formally accepted by the WWTF Board of Directors.

The governing body is the WWTF Board of Directors. It is complemented by the WWTF Ad-visory Board composed of Viennese scientists and representatives from the economy, socie-ty and politics. WWTF office manages all funding activities and is the contact point for all applicants.

(3)

3

Important Issues

The Call Fiche including contact information of WWTF call managers is available at

www.wwtf.at. The formal criteria for a WWTF LS 2016 project include a minimum funding volume of 200.000 € with an upper range of up to 1.000.000 € and a planned duration of 2-4 years.

The Coordinator of a WWTF project must be affiliated to a Viennese home institution,. This includes researchers moving to Vienna with a Viennese affiliation and work place in case of funding. Project partners outside of Vienna may receive funding of up to 30% of the total funding applied for. Partners outside Vienna are an option; they are neither obligatory nor a formal criterion for acceptance.

At universities, WWTF projects are carried out according to §27 of the “Universitätsgesetz 2002”; authorized signatures from the university / scientific institution acting as the home institution are therefore mandatory at the submission stage. In case of funding, the institution will be the formal contract partner for WWTF with the coordinator taking full scientific and financial responsibility.

WWTF funding may be used for all project-related costs; however, the main focus should be on funding scientific personnel. Everybody employed in a WWTF-funded project should get a fair contract with a wage according to the “Kollektivvertrag” (collective agreement) of the Aus-trian Universities or – for staff employed at non-university research institutions – according to the standards of the Austrian Science Fund (FWF) available online at https://www.fwf.ac.at/fileadmin/files/Dokumente/Personalkostensaetze/pek-2015.pdf. A

max-imum total employment is set at 100%. The personnel categories are:

Senior Personnel: highly qualified scientists, usually already in permanent employment Post Doc: or equivalent qualification, including Senior Postdocs

PhD Student: or equivalent qualification

Diploma Student: Bachelor or Master students

Office/Technician: office staff or technical staff (proportional funding only)

The funding by WWTF under this scheme is not intended to cover investment in general in-frastructure, however pro rata depreciation rates for the project duration are fundable for equipment necessary for the project. WWTF funding also covers materials (consumables and small devices up to 1,500 € each), travelling costs (incurred for attending project relat-ed scientific events and invitations), publication costs (including cost for patent filing and open access publication), workshops / conferences (costs incurred by own scientific events), and other project related costs.

WWTF pays a maximum of 20% overhead. Overhead (“indirect costs”) is calculated as 20% of the direct costs of the project. The total funding volume is calculated as direct + indi-rect costs. A separate project account / SAP number for bookkeeping is necessary for each

(4)

4

project and the direct costs must be reported to WWTF. The overhead is paid as a flat rate with no strings attached. Kindly stick to the overhead regulations of the involved institutions. Compliance with the rules for good scientific practice is mandatory even at the proposal stage.

Funding Criteria

This WWTF call aims to support cutting-edge research projects on precision medicine to im-prove diagnoses and/or prognoses of diseases as well as stratified therapeutic strategies in humans. High quality Omics data (e.g. genomics, epigenomics, proteomics, metabolomics, microbiomics), disease- or therapeutic-oriented functional data and/or innovative imaging data should be integrated to answer relevant clinical questions. All projects should be com-plemented by a research concept, considering system medicine approaches for a better un-derstanding of disease and therapeutic response.

Collaboration between different scientific disciplines such as biology, medicine and systems biology is mandatory. Proposals should address innovative technologies such as Omics technologies (e.g., genomics, epigenomics, proteomics, metabolomics, microbiomics), dis-ease- or therapeutic-oriented functional and/or imaging analyses.

The key selection criterion for this call is an outstanding scientific quality under the scopus of the call, which includes the objectives of the project as well as the scientific expertise of the applicants. Innovation and clinical relevance of the project is one major criterion in the review process. Projects missing an appropriate concept to cover a system medi-cine/biology approach will not be considered for further evaluation.

In order to assess and evaluate, if the proposed research project meets the required criteria, the above points need to be clearly outlined within the proposal.

Please note that a researcher can appear as Principal Investigator in two proposals at most.

Evaluation Process

In this call a two-stage submission process is used: first, a short proposal of a maximum of four pages shall be submitted describing the key objectives and research goals for the pro-posed work as outlined in the Call Fiche. Second, if the short proposal is successful, the ap-plicants are invited to submit a full proposal. Short proposals may be submitted at any time from the opening of the call until the final closure date (15-01-2016). Full proposals can only be submitted upon invitation by 13-05-2016 at the latest.

(5)

5

Evaluation procedure in detail:

1. Formal eligibility check by WWTF: Initially the proposals will be screened for formal eli-gibility by the WWTF office based on the following criteria: Coordinator is affiliated to a Viennese research institution | a researcher does not appear as principal investigator on more than two proposals | not more than 30% of the funding budget is allocated outside of Vienna | duly submitted | funding range between 200.000 € and 1.000.000 € | required signa-tures | all necessary parts filled in | length of the proposal not exceeded. Proposals that do not meet the key requirements outlined will not be sent for further evaluation to the jury. Applicants deemed ineligible will be informed shortly after the submission deadline. 2. Evaluation of short proposals: If the proposal is not rejected for formal reasons, it will be evaluated by the jury. The evaluation process is based on the following major criteria: Quali-ty (scientific originaliQuali-ty and excellence of the proposed research project), Innovation and clinical relevance (which aspects of the proposed project are especially innovative?), Scope of the call (projects should meet the requirements as previously stated), Collabora-tion and expertise of the consortium, Feasibility of the working plan.

Unsuccessful applicants will be informed promptly about rejections and receive a brief sum-mary of the evaluations of the jury.

3. Evaluation of full proposals: If the short proposal fulfils the requirements, the applicants are invited to submit a full proposal by 13-05-2016. The objectives of the full proposal must be consistent and in accordance with the successful short proposal, extending it by providing full details about the approach, the specific work plan etc. Full proposals should not exceed the size limits indicated in the submission system. A guide for writing the full proposal will be provided in due time. The evaluation of full proposals is carried out through a combination of remote assessment and panels of international experts that convene in Vienna. Two jury members are assigned to each proposal, which at first undergoes written peer review by at least three international reviewers.

4. Jury meeting in Vienna in late fall 2016: Most significant step in the assessment- com-prehensive evaluation of all proposals on the basis of written peer reviews and the jury’s own expertise resulting in a recommendation “to be funded” or “not to be funded” for each pro-posal.

5. Formal funding decision (confirmation of jury recommendation) by WWTF Board of Di-rectors in October 2016.

Applicants will receive anonymized full text reviews and a summary of the jury discussion after the formal funding decision.

(6)

6

How to use WWTF’s Online Submission System

1. Go to https://funding.wwtf.at

2. Register with your mail address and name: the password will be sent to you via e-mail. If you submitted in a former call, you can reuse this login data.

3. Log in, choose the call, and create a new proposal.

4. Write a short proposal: fill in requested information in online forms and upload

re-quested files (in PDF format). You can access the system multiple times and modify

provided information anytime.

5. Submit proposal: the submit button becomes active only after all requested infor-mation has been filled in and uploaded; after submission no changes are possible anymore.

Note: The submission system closes at 2 pm on the day of the deadline. The short proposal has a size limit of maximum 10 MB.

Required Structure of a WWTF Short Proposal

Applications to WWTF undergo an assessment by international scientists, thus all proposals must be written in English. A short proposal should not exceed 5 pages excluding appendix. Please, write precisely and to the point. Note that proposals that exceed the maximum num-ber of pages are not eligible.

A short proposal to WWTF comprises nine parts: 1. Basic information

2. Information about the principal investigators 3. Project summary

3. Objectives and hypotheses

4. Innovativeness and clinical relevance 5. Ultimate goal of the project

6. Research methods and feasibility 7. Role of the participating project leaders 8. Ethical aspects

9. Key references

10. Affirmations and authorization 11. Appendix

(7)

7

I. Basic Information

This part has to be filled in the online forms in the submission system. It includes the Title of the project, Name of the Principal Investigator and Coordinator (one of the Principle

In-vestigators has to be defined as coordinator), Keywords (up to five), the indicative project duration (between 2 and 4 years) as well as the indicative budget (approximately within

the range of 200.000-1.000.000 Euros).

II. Information about the Principal Investigators

Name and full contact information of the Principal Investigators (PIs) including the home institutions, where the PIs intend to run the project, is required. One of the PIs has to be de-fined as coordinator and will be the sole responsible person towards WWTF. Altogether, not more than 3 PIs should be stated in this section. Furthermore, information about the Principle Investigators scientific expertise, time commitment in percentage as well as a budget split in percentage has to be given. In the latter case the sum must equal 100%.

III. Project Summary (approx. 1500 characters including spaces)

This part must provide a complete project summary. Briefly, outline the state of the art, the aims of your proposal and how you plan to achieve these. State clearly, why in your opinion, this research idea is particularly fitting to the WWTF Precision Medicine Call? Why should the jury consider your research idea?

IV. Objectives and hypotheses (approx. 3000 characters including

spac-es)

Provide an outline of the scientific approach, that will be used to reach your objectives. The objectives should be achievable within the duration of your project. State background infor-mation, preliminary data including existing patient cohorts and associated research experi-ence. The quality of biobanks and their link to clinical information needs to be described in detail as it will be one important evaluation criterion. If there are already published articles on the patient cohorts, please, indicate this.

IV. Innovativeness and clinical relevance (approx. 1000 characters

in-cluding spaces)

What is/are the scientific challenge/s the project wants to address? What are the innovative aspects of your proposal? Describe the clinical relevance of the proposed work for the field of precision medicine.

(8)

8

V. Ultimate goals of the project (approx. 1000 characters including

spac-es, 1 PDF Gantt chart)

Use the text box and upload a Gantt chart to indicate an overview of milestones to be achieved during the project period. Specify the time periods and the respective PIs responsi-ble for each milestone.

VI. Research methods and feasibility (approx. 2000 characters including

spaces)

By which methods do you aim to reach the objectives of the project? Include a short as-sessment on the feasibility and possible pitfalls of the project. A comment on whether pro-jects can be co-financed by other sources can be added, if it helps to clarify things. Particular information is required with regard to clinical scientists. Power calculations should be added wherever possible to assess whether available sample numbers are sufficient to reach rele-vant statistical conclusions?

VII. Role of the participating project leaders within the consortium

(ap-prox. 2000 characters including spaces)

Each team member should describe his/her role in achieving the goal of the team as a whole. Which different disciplines are working together within your research and what is the benefit of the participants to achieve the ultimate goal of the project?

V. Ethical aspects (500 characters including spaces)

Information should be given with respect to the ethical approval, required for the patient co-hort. Is an ethical approval available, which covers the prospective use of data and the planned analysis? If not, describe the additional approval needed.

VI. Key References (approx. 1000 characters)

Cite the most relevant background literature (max. 10) for the proposal.

VII. Affirmations and Authorization

WWTF requires the Principal Investigators to upload the signed affirmation forms. In addition, WWTF requires an upload of signatures of the authorized person(s) of all participating institu-tions, to which the persons signing the “Authorization” are affiliated, in case of funding. Multi-ple copies might be used for signing.

(9)

9

VIII. Appendix

In the appendix please upload a “Biographical Sketch” (limited to a maximum of two pages) for the Principal Investigators. The “Biographical Sketch” should consist of a 1-page CV and a 1-page List of Publications (limited to a maximum of ten publications).

A Biographical Sketch must contain the following information: (i) Higher education including obtained degrees and dates when received (ii) Appointments

A list, in reverse chronological order, of all the individual´s academic/professional appoint-ments or other work experience.

(iii) Funded projects

A list of up to 3 funded projects incl. project duration, funding source, granted amount of money and the role played in each project.

(iv) Other relevant activities/ experience

A list demonstrating the broader impact of the individual’s professional and scholarly activi-ties that focuses on the creation, integration, and transfer of knowledge.

(v) A list of five of the most relevant cooperations. Indicate the names and nature of the co-operation.

List of Publications:

A list of up to ten peer-reviewed publications published over the last 5 years. Mark publica-tions, most relevant to the proposed research, with an asterisk (*).

In Case of Funding

The Formal Funding Contract will be made between WWTF and the Home Institution of the Principal Investigator (for universities according to §27 of the University Law 2002), the coor-dinator has full scientific and financial responsibility. Projects may start shortly (and not later than 6 months) after the formal funding decision has been made. During the project duration WWTF pays funding rates half a year in advance to the coordinator’s Home Institution, which is then responsible for distribution to other institutions (if applicable).

WWTF monitoring during the runtime of projects includes annual short reports delivered by the coordinator to WWTF with an overview on the scientific results achieved, personnel em-ployment and funding spent. WWTF office also makes site-visits to learn about the project progress and working environment of the personnel employed. WWTF offers the possibility to adopt the work plan according to the project’s needs.

(10)

10

After the project has ended a comprehensive final report must be submitted and WWTF or-ganizes an ex-post evaluation by international peers („Evaluation Day“) for all projects funded within a specific call.

References

Related documents

The level of financial support must be equivalent to the current voluntary extended care and support (V9) agreement pursuant to section 4037-A and in accordance with DHHS, Office

- If follicular cells show Hurthle cell change, called Hurthle cell adenoma - Atypia might be present, but does not mean malignancy (Atypia is normally. common in

The technologies available for removal of CO 2 from dairy manure biogas are typically used for larger scale applications such as upgrading natural gas from “sour” gas wells,

• 80 percent of revenue in fiscal 2002 was generated by residential land uses; 19 percent by commercial land uses; and 1 percent by farm, forest and open lands, • 95 percent

We hypothesised that adults’ own alcohol consumption, their age of initiation, and social norms about alcohol consumption would be associated with the perceived acceptability

How Many Breeding Females are Needed to Produce 40 Male Homozygotes per Week Using a Heterozygous Female x Heterozygous Male Breeding Scheme With 15% Non-Productive Breeders.

group of defect two is permutable, the finite solvable groups in which9. every normal subgroup is permutable sensitive, and the